Acrivon Therapeutics Inc (ACRV)
NASDAQ
Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | ||||||
Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating Income | -9.58M | -9.95M | -14.39M | -15.52M | -16.14M | -21.05M | -17.67M | -21.44M |
Pre Tax Income | -9.2M | -8.93M | -12.76M | -13.91M | -14.47M | -19.25M | -16.49M | -18.8M |
Net Income | -9.2M | -8.93M | -12.76M | -13.91M | -14.47M | -19.25M | -16.49M | -18.8M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBIT | -9.2M | -8.93M | -12.76M | -13.91M | -14.47M | -21.44M | -17.93M | -21.49M |
EBITDA | -9.46M | -9.82M | -14.27M | -15.39M | -16M | -20.9M | -17.44M | -21.21M |
Year End December 30 2023 | 2021 | 2022 | 2023 |
---|---|---|---|
USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 0 | 0 |
Operating Income | -16.18M | -32.66M | -67.1M |
Pre Tax Income | -16.24M | -31.17M | -60.39M |
Net Income | -16.24M | -31.17M | -60.39M |
Preferred Dividends | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.51 | -0.462 | -1.216 |
EBIT | -16.18M | -31.17M | -67.49M |
EBITDA | -16.15M | -32.29M | -66.57M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.